Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Effect of daily consumption of extra virgin olive oil on the lipid profile and microbiota of HIV-infected patients over 50 years of age.

Olalla J, García de Lomas JM, Chueca N, Pérez-Stachowski X, De Salazar A, Del Arco A, Plaza-Díaz J, De la Torre J, Prada JL, García-Alegría J, Fernández-Sánchez F, García F.

Medicine (Baltimore). 2019 Oct;98(42):e17528. doi: 10.1097/MD.0000000000017528.

2.

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316).

Pérez Elías MJ, Alejos B, Vivancos MJ, Ribera E, Galindo MJ, Vilanova-Trillo L, García-Fraile Fraile LJ, de La Fuente Moral S, Garcia De Lomas J, Lozano F, Mateo García MG, Tasias Pitarch M, Diez Martinez M, Rojas J, Raya-Cruz M, Sepúlveda MA, Troya J, Del Campo S, Martinez E.

J Antimicrob Chemother. 2019 Oct 1;74(10):3124. doi: 10.1093/jac/dkz331. No abstract available.

PMID:
31377772
3.

Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 48 weeks.

Pérez-Stachowski J, Tortajada B, Del Arco A, Márquez E, De la Torre J, Nieto M, García de Lomas JM, Prada JL, García-Alegría J, Olalla J.

Infect Dis (Lond). 2019 Sep;51(9):691-693. doi: 10.1080/23744235.2019.1637536. Epub 2019 Jul 5.

PMID:
31272264
4.

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316).

Pérez Elías MJ, Alejos B, Vivancos MJ, Ribera E, Galindo MJ, Vilanova-Trillo L, García-Fraile Fraile LJ, de La Fuente Moral S, Garcia De Lomas J, Lozano F, Mateo García MG, Tasias Pitarch M, Diez Martinez M, Rojas J, Raya-Cruz M, Sepúlveda MA, Troya J, Del Campo S, Martinez E; CODAR study group .

J Antimicrob Chemother. 2019 Oct 1;74(10):3044-3048. doi: 10.1093/jac/dkz254.

PMID:
31236601
5.

Experience of Using an App in HIV Patients Older Than 60 Years: Pilot Program.

Olalla J, García de Lomas JM, Márquez E, González FJ, Del Arco A, De La Torre J, Prada JL, Cantudo F, Martín MD, Nieto M, Perez Stachowski J, García-Alegría J.

JMIR Mhealth Uhealth. 2019 Mar 6;7(3):e9904. doi: 10.2196/mhealth.9904.

6.

Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks.

Olalla J, Pérez-Stachowski J, Tortajada B, Del Arco A, Márquez E, De la Torre J, Nieto M, García de Lomas JM, Prada JL, García-Alegría J.

BMC Pharmacol Toxicol. 2018 Oct 10;19(1):63. doi: 10.1186/s40360-018-0252-z.

7.

Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection: results from a multi-center, cross-sectional study in Spain.

Escribano Montaner A, García de Lomas J, Villa Asensi JR, Asensio de la Cruz O, de la Serna Blázquez O, Santiago Burruchaga M, Mondéjar López P, Torrent Vernetta A, Feng Y, Van Dyke MK, Reyes J, Garcia-Corbeira P, Talarico CA; EPI-Strep-064 study group.

Eur J Pediatr. 2018 Feb;177(2):181-192. doi: 10.1007/s00431-017-3044-3. Epub 2017 Dec 29.

8.

The Arctic Ocean as a dead end for floating plastics in the North Atlantic branch of the Thermohaline Circulation.

Cózar A, Martí E, Duarte CM, García-de-Lomas J, van Sebille E, Ballatore TJ, Eguíluz VM, González-Gordillo JI, Pedrotti ML, Echevarría F, Troublè R, Irigoien X.

Sci Adv. 2017 Apr 19;3(4):e1600582. doi: 10.1126/sciadv.1600582. eCollection 2017 Apr.

9.

Seroprevalence of pertussis amongst healthcare professionals in Spain.

Rodríguez de la Pinta ML, Castro Lareo MI, Ramon Torrell JM, García de Lomas J, Devadiga R, Reyes J, McCoig C, Tafalla M, García-Corbeira P.

Vaccine. 2016 Feb 17;34(8):1109-14. doi: 10.1016/j.vaccine.2015.12.036. Epub 2015 Dec 22.

10.

Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.

Diez-Domingo J, Weinke T, Garcia de Lomas J, Meyer CU, Bertrand I, Eymin C, Thomas S, Sadorge C.

Vaccine. 2015 Feb 4;33(6):789-95. doi: 10.1016/j.vaccine.2014.12.024. Epub 2014 Dec 30.

11.

Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain.

Puig-Barberà J, García-de-Lomas J, Díez-Domingo J, Arnedo-Pena A, Ruiz-García M, Limón-Ramírez R, Pérez-Vilar S, Micó-Esparza JL, Tortajada-Girbés M, Carratalá-Munuera C, Larrea-González R, Beltrán-Garrido JM, Otero-Reigada Mdel C, Mollar-Maseres J, Correcher-Medina P, Schwarz-Chavarri G, Gil-Guillén V; Valencia Hospital Network for the Study of Influenza and Respiratory Virus Disease.

PLoS One. 2014 Nov 13;9(11):e112294. doi: 10.1371/journal.pone.0112294. eCollection 2014.

12.

Plastic debris in the open ocean.

Cózar A, Echevarría F, González-Gordillo JI, Irigoien X, Ubeda B, Hernández-León S, Palma AT, Navarro S, García-de-Lomas J, Ruiz A, Fernández-de-Puelles ML, Duarte CM.

Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10239-44. doi: 10.1073/pnas.1314705111. Epub 2014 Jun 30.

13.

Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients.

Crespo M, Collado S, Mir M, Cao H, Barbosa F, Serra C, Hidalgo C, Faura A, Montero M, García de Lomas J, Horcajada JP, Puig JM, Pascual J.

Clin J Am Soc Nephrol. 2011 Sep;6(9):2208-14. doi: 10.2215/CJN.02160311. Epub 2011 Aug 18.

14.

Becton Dickinson Directigen EZ Flu A+B assay in the diagnosis of pandemic influenza A H1N1 2009 virus infection in adult patients.

Nogueira JM, Alberola J, Alcaraz MJ, García de Lomas J, Navarro D.

Influenza Other Respir Viruses. 2011 May;5(3):146-7. doi: 10.1111/j.1750-2659.2010.00194.x. Epub 2011 Jan 25. No abstract available.

15.

Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).

Pérez-Trallero E, Martín-Herrero JE, Mazón A, García-Delafuente C, Robles P, Iriarte V, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for Respiratory Pathogens.

Antimicrob Agents Chemother. 2010 Jul;54(7):2953-9. doi: 10.1128/AAC.01548-09. Epub 2010 May 3.

16.

beta-lactam susceptibility of Escherichia coli isolates from urinary tract infections exhibiting different resistance phenotypes.

Lerma M, Cebrián L, Giménez M, Coronel P, Gimeno M, Aguilar L, García de Lomas J.

Rev Esp Quimioter. 2008 Sep;21(3):149-52.

17.

Evaluation of the in-vitro cidal activity and toxicity of a novel peroxygen biocide: 2-butanone peroxide.

García-de-Lomas J, Lerma M, Cebrián L, Esteban E, Giménez MJ, Aguilar L, Domínguez V, Randez JJ.

J Hosp Infect. 2008 Mar;68(3):248-54. doi: 10.1016/j.jhin.2007.12.011. Epub 2008 Mar 4.

PMID:
18289719
18.

Increasing telithromycin resistance among Streptococcus pyogenes in Europe.

Richter SS, Heilmann KP, Dohrn CL, Beekmann SE, Riahi F, Garcia-de-Lomas J, Ferech M, Goossens H, Doern GV.

J Antimicrob Chemother. 2008 Mar;61(3):603-11. doi: 10.1093/jac/dkm525. Epub 2008 Jan 24.

PMID:
18218647
19.

Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences.

Gobernado M, Valdés L, Alós JI, Garcia-Rey C, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for E. coli Urinary Pathogens.

Rev Esp Quimioter. 2007 Jun;20(2):206-10.

20.

Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae.

Riedel S, Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J, Ferech M, Goosens H, Doern GV.

Eur J Clin Microbiol Infect Dis. 2007 Jul;26(7):485-90.

PMID:
17551759
21.

Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.

Gobernado M, Valdés L, Alós JI, García-Rey C, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for Urinary Pathogens.

Rev Esp Quimioter. 2007 Mar;20(1):68-76.

22.

Nitrate stimulation of indigenous nitrate-reducing, sulfide-oxidising bacterial community in wastewater anaerobic biofilms.

Garcia-de-Lomas J, Corzo A, Carmen Portillo M, Gonzalez JM, Andrades JA, Saiz-Jimenez C, Garcia-Robledo E.

Water Res. 2007 Jul;41(14):3121-31. Epub 2007 May 23.

PMID:
17524444
23.

Influence of Haemophilus influenzae beta-lactamase production and/or ftsI gene mutations on in vitro activity of and susceptibility rates to aminopenicillins and second- and third-generation cephalosporins.

García-de-Lomas J, Lerma M, Cebrián L, Juan-Bañón JL, Coronel P, Giménez MJ, Aguilar L.

Int J Antimicrob Agents. 2007 Aug;30(2):190-2. Epub 2007 Apr 25. No abstract available.

PMID:
17459665
24.

The Meropenem Yearly Susceptibility Test Information Collection antimicrobial susceptibility program in Spain: a 5-year analysis.

Pascual A, Perea E, Alvarez M, Casal M, Garcia de Lomas J, Garcia Rodríguez JA, Martin R, Soria G, Zapardiel J; Spanish MYSTIC group.

Diagn Microbiol Infect Dis. 2007 Feb;57(2):195-200. Epub 2006 Oct 18.

PMID:
17052882
25.
26.

Etiological misidentification by routine biochemical tests of bacteremia caused by Gordonia terrae infection in the course of an episode of acute cholecystitis.

Gil-Sande E, Brun-Otero M, Campo-Cerecedo F, Esteban E, Aguilar L, García-de-Lomas J.

J Clin Microbiol. 2006 Jul;44(7):2645-7.

27.

Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with Prevenar in children with underlying chronic or recurrent lung diseases.

Navarro D, Escribano A, Cebrián L, Gimeno C, García-Maset L, García-de-Lomas J; Spanish Pneumococcal Infection Study Network.

Clin Vaccine Immunol. 2006 Jun;13(6):665-70.

28.

Nitrate promotes biological oxidation of sulfide in wastewaters: experiment at plant-scale.

García de Lomas J, Corzo A, Gonzalez JM, Andrades JA, Iglesias E, Montero MJ.

Biotechnol Bioeng. 2006 Mar 5;93(4):801-11.

PMID:
16255035
29.

Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain.

Pérez-Trallero E, García-de-la-Fuente C, García-Rey C, Baquero F, Aguilar L, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for Respiratory Pathogens.

Antimicrob Agents Chemother. 2005 May;49(5):1965-72.

30.

Survey of emm-like gene sequences from pharyngeal isolates of group C and group G streptococci collected in Spain.

Albertí S, García-Rey C, García-Laorden MI, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for Respiratory Pathogens.

J Clin Microbiol. 2005 Mar;43(3):1433-6.

31.
32.

Performance of the Binax NOW Streptococcus pneumoniae urinary antigen assay for diagnosis of pneumonia in children with underlying pulmonary diseases in the absence of acute pneumococcal infection.

Navarro D, García-Maset L, Gimeno C, Escribano A, García-de-Lomas J; Spanish Pneumococcal Infection Study Network.

J Clin Microbiol. 2004 Oct;42(10):4853-5.

33.

Evolution of penicillin and erythromycin co-resistance in Streptococcus pneumoniae in Spain.

García-Rey C, Bouza E, Aguilar L, García-de-Lomas J, Baquero F; Spanish Surveillance Group for Respiratory Pathogens.

Int J Antimicrob Agents. 2003 Nov;22(5):541-4.

PMID:
14602376
34.

Susceptibility patterns of bacteria causing community-acquired respiratory infections in Spain: the SAUCE project.

García-De-Lomas J, García-Rey C, López L, Gimeno C.

J Antimicrob Chemother. 2002 Dec;50 Suppl S2:21-6.

PMID:
12556430
35.

Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin.

Latorre C, García-Rey C, García-Perea A, Perea E, Aguilar L, Cercenado E, García-de-Lomas J; Spanish Surveillance Group for Respiratory Pathogens.

J Antimicrob Chemother. 2002 Aug;50(2):301-3. No abstract available.

PMID:
12161418
36.

Activities of six different quinolones against clinical respiratory isolates of Streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain.

Pérez-Trallero E, García-Rey C, Martín-Sánchez AM, Aguilar L, García-de-Lomas J, Ruiz J; Spanish Surveillance Group for Respiratory Pathogens (SAUCE Program).

Antimicrob Agents Chemother. 2002 Aug;46(8):2665-7.

37.

Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.

Pérez-Trallero E, Fernández-Mazarrasa C, García-Rey C, Bouza E, Aguilar L, García-de-Lomas J, Baquero F; Spanish Surveillance Group for Respiratory Pathogens.

Antimicrob Agents Chemother. 2001 Dec;45(12):3334-40.

38.

Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999.

Marco F, García-de-Lomas J, García-Rey C, Bouza E, Aguilar L, Fernández-Mazarrasa C; Spanish Surveillance Group for Respiratory Pathogens.

Antimicrob Agents Chemother. 2001 Nov;45(11):3226-8.

41.

Immunological diagnosis of human hydatid cyst relapse: utility of the enzyme-linked immunoelectrotransfer blot and discriminant analysis.

Gadea I, Ayala G, Diago MT, Cuñat A, Garcia de Lomas J.

Clin Diagn Lab Immunol. 2000 Jul;7(4):549-52.

42.

Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study.

García-Corbeira P, Dal-Ré R, Aguilar L, García-de-Lomas J.

Vaccine. 2000 Apr 28;18(21):2173-6.

PMID:
10717335
43.

A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A.

Dal-Ré R, García-Corbeira P, García-de-Lomas J.

J Med Virol. 2000 Apr;60(4):363-6.

PMID:
10686017
44.

Whole cell lysate enzyme immunoassays vs. recombinant glycoprotein G2-based immunoassays for HSV-2 seroprevalence studies.

García-Corbeira P, Hogrefe W, Aguilar L, García-de-Lomas J, Gil A, Bayas JM, Vilella A, Dal-Ré R.

J Med Virol. 1999 Dec;59(4):502-6.

PMID:
10534733
45.
46.

Is sexual transmission an important pattern for herpes simplex type 2 virus seroconversion in the Spanish general population?

García-Corbeira P, Dal-Ré R, Aguilar L, Granizo JJ, García-de-Lomas J.

J Med Virol. 1999 Oct;59(2):194-7.

PMID:
10459155
47.

[Accreditation and certification of laboratories of clinical microbiology? Yes, but are ENAC and AENOR adequate?].

García de Lomas J, Farga A, Gimeno C.

Enferm Infecc Microbiol Clin. 1999 Mar;17(3):111-2. Spanish. No abstract available.

PMID:
10217844
48.

Low prevalence of diphtheria immunity in the Spanish population: results of a cross-sectional study.

García-Corbeira P, Dal-Ré R, García-de-Lomas J, Aguilar L.

Vaccine. 1999 Apr 9;17(15-16):1978-82.

PMID:
10217597
49.

[Sensitivity of group A beta-hemolytic Streptococcus isolated from pediatric pharyngotonsillitis to erythromycin and clarithromycin: a primary care multicenter study].

García de Lomas J, Gimeno C, Díez J, Bermejo M, Navarro D, García-Ponte L.

Enferm Infecc Microbiol Clin. 1999 Jan;17(1):24-8. Spanish.

PMID:
10069109

Supplemental Content

Loading ...
Support Center